Cohen & Steers, Inc. (CNS)
- Previous Close
73.76 - Open
74.02 - Bid 37.00 x 900
- Ask 116.81 x 800
- Day's Range
72.80 - 74.02 - 52 Week Range
50.05 - 78.58 - Volume
216,571 - Avg. Volume
286,385 - Market Cap (intraday)
3.705B - Beta (5Y Monthly) 1.42
- PE Ratio (TTM)
28.53 - EPS (TTM)
2.57 - Earnings Date Jul 17, 2024 - Jul 22, 2024
- Forward Dividend & Yield 2.36 (3.22%)
- Ex-Dividend Date May 10, 2024
- 1y Target Est
69.00
Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries. The firm launches and manages equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. Through its subsidiaries, it also launches and manages hedge funds. The firm invests in public equity, fixed income, and commodity markets across the globe through its subsidiaries. Through its subsidiaries, it invests in companies operating in the real estate sector, including real estate investment trusts, infrastructure sector, and natural energy resources sector for its equity and fixed income investments. The firm also invests in preferred securities for its fixed income investments through its subsidiaries. The firm is a leading global investment manager specializing in real assets and alternative income, including real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Cohen & Steers, Inc. was founded in 1986 and is based in New York.
www.cohenandsteers.com405
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CNS
Performance Overview: CNS
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNS
Valuation Measures
Market Cap
3.71B
Enterprise Value
3.67B
Trailing P/E
28.53
Forward P/E
24.81
PEG Ratio (5yr expected)
3.07
Price/Sales (ttm)
7.26
Price/Book (mrq)
9.78
Enterprise Value/Revenue
7.31
Enterprise Value/EBITDA
18.88
Financial Highlights
Profitability and Income Statement
Profit Margin
26.27%
Return on Assets (ttm)
15.32%
Return on Equity (ttm)
29.79%
Revenue (ttm)
486.26M
Net Income Avi to Common (ttm)
127.74M
Diluted EPS (ttm)
2.57
Balance Sheet and Cash Flow
Total Cash (mrq)
177.45M
Total Debt/Equity (mrq)
29.77%
Levered Free Cash Flow (ttm)
110.34M
Research Analysis: CNS
Company Insights: CNS
CNS does not have Company Insights